Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
British Journal of Sports Medicine|February 15, 2022
Association between thermal responses, medical events, performance, heat acclimation and health status in male and female elite athletes during the 2019 Doha World Athletics ChampionshipsSebastien Racinais, George Havenith, Polly Aylwin, et al.
Thrombosis Research|October 10, 2020
Thrombin generation in subjects with lupus anticoagulant without prior thrombosis or gestational morbiditiesDiego Velasco-Rodríguez, Rosa Vidal Laso, Aránzazu García-Raso, et al.
Journal of Clinical Pathology|June 24, 2018
Essential thrombocythaemia with mutation in <i>MPL</i>: clinicopathological correlation and comparison with <i>JAK</i>2V617F-mutated and <i>CALR-</i>mutated genotypesAlberto Alvarez-Larran, Daniel Martínez, Leonor Arenillas, et al.
British Journal of Haematology|August 4, 2020
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential ThrombocythaemiaAlberto Alvarez-Larrán, Anna Angona, Marcio Andrade-Campos, et al.
Sports Medicine (Auckland, N.Z.)|July 15, 2021
Managing Travel Fatigue and Jet Lag in Athletes: A Review and Consensus StatementDina C Janse van Rensburg, Audrey Jansen van Rensburg, Peter M Fowler, et al.
Leukemia Research|July 12, 2025
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndromeJames M Foran, Guillermo F Sanz, Justin M Watts, et al.
Cancers|January 21, 2023
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Rosa Ayala, María José Larráyoz, et al.
Leukemia|February 2, 2021
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemiaBruno Paiva, María-Belen Vidriales, Amparo Sempere, et al.
Leukemia|July 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemiaGonzalo Carreño-Tarragona, Rodrigo Gil-Manso, Juan Carlos Hernández-Boluda, et al.
Cancers|February 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase InhibitorsLucía Pérez-Lamas, Alejandro Luna, Concepción Boque, et al.
Pageof 10